CLINICAL_TRIALS
trial_result
· 2013-01-16
Clinical Trial Update: Chemotherapy Plus Monoclonal Antibody in Treating Patients With Acute Promyelocytic Leukemia [Phase 2]
Summary
Phase 2 clinical trial evaluating chemotherapy plus a monoclonal antibody in patients with acute promyelocytic leukemia has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Leukemia | Phase 2 | Status: COMPLETED